Alessandro Sannino
Corporate Officer/Principal en University of Salento .
Fortuna: 2 410 $ al 31/12/2023
Cargos activos de Alessandro Sannino
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| University of Salento | Corporate Officer/Principal | 01/09/2000 | - |
Historial de carrera de Alessandro Sannino
Antiguos cargos conocidos de Alessandro Sannino.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| GELESIS HOLDINGS, INC. | Corporate Officer/Principal | 13/01/2022 | 30/10/2023 |
| GELESIS INC | Corporate Officer/Principal | 01/05/2008 | 01/01/2022 |
Academica Life Science SRL
 Academica Life Science SRL Miscellaneous Commercial ServicesCommercial Services Academica Life Science SRL develops biodegradable superabsorbent hydro gels. The company was founded by Luigi Ambrosio, Luigi Nicolais and Alessandro Sannino in 2006 and is headquartered in Naples, Italy | Fundador | 26/05/2010 | - |
| Presidente | 01/04/2006 | - |
Formación de Alessandro Sannino.
| Università degli Studi di Napoli Federico II | Doctorate Degree |
| University of Washington | Doctorate Degree |
Estadísticas
Internacional
| Italia | 4 |
| Estados Unidos | 4 |
Operativa
| Corporate Officer/Principal | 3 |
| Doctorate Degree | 2 |
| Founder | 1 |
Sectorial
| Consumer Services | 4 |
| Health Technology | 3 |
| Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| GELESIS HOLDINGS, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Academica Life Science SRL
Academica Life Science SRL Miscellaneous Commercial ServicesCommercial Services Academica Life Science SRL develops biodegradable superabsorbent hydro gels. The company was founded by Luigi Ambrosio, Luigi Nicolais and Alessandro Sannino in 2006 and is headquartered in Naples, Italy | Commercial Services |
Gelesis, Inc.
 Gelesis, Inc. BiotechnologyHealth Technology Gelesis, Inc. operates as a consumer-centered biotherapeutics company, which engages in the development of novel therapies to induce weight loss and metabolic disorders. Its commercial product portfolio includes Plenity, an FDA-cleared product to aid in weight management, as well as potential therapies in development for patients with Type 2 Diabetes, Non-alcoholic Fatty Liver Disease /Non-alcoholic Steatohepatitis, and Functional Constipation. The company was founded by Yishai Zohar in 2006 and is headquartered in Boston, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Alessandro Sannino
- Experiencia
